UNSPSC 51141594: Milacemide hydrochloride

This classification denotes an anticonvulsant agent with the molecular formula C7H16N2O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6XK4G40F6W, chemically known as acetamide, 2-(pentylamino)-, monohydrochloride but more generally known as milacemide hydrochloride, which bears US NIH Compound Identifier 53568. Most nations, for tariff and trade purposes, schedule milacemide hydrochloride under HS 29241900 and SITC 51471. As of Q4 2014, MILACEMIDE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity.

Milacemide hydrochloride bears US NLM identifiers UMLS ID C2825649 and NCI Concept Code C81470. SMILES: CCCCCNCC(=O)N.CL.

UNSPSC 51141594 Milacemide hydrochloride is a Commodity code that nominally covers a specific pharmaceutical compound, but recent state and local procurement activity under this code shows no substantive purchasing of milacemide hydrochloride itself. Instead, the single recent opportunity tagged to this code reflects a mismatch between the code assignment and the actual scope of work being solicited. State and local governments do not appear to be using this code actively for its intended pharmaceutical purpose at present.

Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, seeking to procure 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with a response deadline of July 26, 2023. The opportunity is unrelated to milacemide hydrochloride; it addresses opioid-overdose response and drug-disposal equipment rather than the neurological agent the code nominally describes. The mismatch suggests either a cataloging error on the issuer's part or a legacy code assignment that does not reflect current purchasing practice. This code does not report meaningful recent state and local activity aligned with its pharmaceutical scope.